Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Abdominal Cancer × Influenza Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Influenza, Human 11 Neoplasms 6 Colorectal Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Myeloid, Acute 3 Pancreatic Neoplasms 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Melanoma 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Waldenstrom Macroglobulinemia 1 Virus Diseases 1 Vaccine-Preventable Diseases 1 Vaccination Hesitancy 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Recurrence 1 Patient Acceptance of Health Care 1 Ovarian Neoplasms 1 Osteosarcoma 1 Older Patients 1 Neuroblastoma 1

Interventions

Tea 2 Bupivacaine 2 Tadalafil 1 Morphine 1 Lidocaine 1 Ketamine 1 Injections, Subcutaneous 1 Influenza Vaccines 1 Ethanol 1 Dexmedetomidine 1 Anesthetics, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02998736 2022-12-28

PERIOP-04

Ottawa Hospital Research Institute

Phase 1 Completed

Abdominal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡